1 period filed. Holdings below describe the selected month only.
NPORT-P · filed 2026-05-26
No share classes in the SEC snapshot.
2,774 filed series have no class in company_tickers_mf.json, so no ticker can be reached for them.
N-PORT Item C.4.a
as filed
N-PORT Item C.4.b
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 85.7% of reported value reaches a classification.
Percentages are of the reported value of positions above ($1.03B), not of the fund’s net assets ($1.00B). The two differ by cash, derivatives filed with no market value, and rounding.
133 positions in this filing
| Issuer↕ | In master | CUSIP / ISIN | Asset | Balance↕ | Value↕ | Weight▲ | Country |
|---|---|---|---|---|---|---|---|
| MEDICAL MICROINSTRUMENTS INC MEDICAL MICROINSTRUMENTS INC WT 02/16/2031 PP | — | — — | EC CORP | 2,363 NS | $25.8K | 0.003% | US |
| ELEVATEBIO, LLC ELEVATEBIO LLC SER C PC PP | — | — — | EP CORP | 31,200 NS | $57.4K | 0.006% | US |
| KARDIUM INC/US KARDIUM INC US SRE D-7 PC PP (1ST CLOSING JUN… | — | — — | EP CORP | 111,115 NS | $60.0K | 0.006% | US |
| WUGEN INC WUGEN INC SER B PC PP | — | — — | EP CORP | 57,585 NS | $89.3K | 0.009% | US |
| SALUDA MEDICAL INC SALUDA MEDICAL INC CDI | — | — AU0000432114 | EC CORP | 300,000 NS | $172.4K AUD | 0.017% | US |
| GALVANIZE THERAPEUTICS GALVANIZE THERAPEUTICS CONV 10% 02/28/2027 P/P | — | — — | DBT CORP | 154,788.38 PA | $202.3K | 0.020% | US |
| ACUMEN PHARMACEUTICALS INC | ABOS | 00509G209 US00509G2093 | EC CORP | 95,526 NS | $225.4K | 0.022% | US |
| SHOULDER INNOVATIONS INC | SI | 82537J108 US82537J1088 | EC CORP | 16,100 NS | $233.9K | 0.023% | US |
| DMED BIOPHARMACEUTICAL CO LTD DMED BIOPHARMACEUTICAL CO LTD SER C PC PP | — | — — | EP CORP | 39,228 NS | $234.2K | 0.023% | CN |
| IMMUNOME INC | IMNM | 45257U108 US45257U1088 | EC CORP | 11,100 NS | $242.8K | 0.024% | US |
| SALUDA MEDICAL INC SALUDA MEDICAL INC (2 YEAR LOCK UP) PP | — | — — | EC CORP | 50,407 NS | $285.2K AUD | 0.028% | US |
| KARDIUM INC/US KARDIUM INC US SRE D-7 PC PP (2ND CLOSING JUN… | — | — — | EP CORP | 534,070 NS | $288.4K | 0.029% | US |
| ALEDADE INC ALEDADE INC SER E1 PC PP | — | — — | EP CORP | 10,776 NS | $289.3K | 0.029% | US |
| ASIMOV INC ASIMOV INC SER B PC PP | — | — — | EP CORP | 13,047 NS | $324.0K | 0.032% | US |
| WUGEN INC WUGEN INC CONV 0% 12/31/2199 P/P | — | — — | DBT CORP | 353,945 PA | $368.5K | 0.037% | US |
| GALVANIZE THERAPEUTICS GALVANIZE THERAPEUTICS SER B PC PERP PP | — | — — | EP CORP | 505,495 NS | $369.0K | 0.037% | US |
| MANUS BIO INC MANUS BIO INC SER ONE-6 PC PP | — | — — | EP CORP | 132,642 NS | $440.4K | 0.044% | US |
| ELEMENT BIOSCIENCES INC ELEMENT BIOSCIENCES INC SER D1 PC PP | — | — — | EP CORP | 73,131 NS | $540.4K | 0.054% | US |
| ELEMENT BIOSCIENCES INC ELEMENT BIOSCIENCES INC SER D PC PP | — | — — | EP CORP | 73,131 NS | $540.4K | 0.054% | US |
| PERCEPTIVE CAPITAL SOLUTIONS CORP FREENOME HOLDINGS INC PIPE | — | — — | EC CORP | 54,857 NS | $548.6K | 0.055% | KY |
| GALVANIZE THERAPEUTICS GALVANIZE THERAPEUTICS SER C-1 PC PERP PP | — | — — | EP CORP | 1,234,125 NS | $555.4K | 0.055% | US |
| ALEDADE INC ALEDADE INC SER B1 PC PP | — | — — | EP CORP | 24,966 NS | $670.3K | 0.067% | US |
| KARDIUM INC/US KARDIUM INC US CONV 10% 12/31/2026 PP | — | — — | DBT CORP | 613,865.85 PA | $674.0K | 0.067% | US |
| CANDID THERAPEUTICS CANDID THERAPEUTICS INC SER B PC PP | — | — — | EP CORP | 491,360 NS | $687.9K | 0.068% | US |
| OCULAR THERAPEUTIX INC | OCUL | 67576A100 US67576A1007 | EC CORP | 83,621 NS | $708.3K | 0.071% | US |
| VIPHLT TUB HOLDINGS LLC VIPHLT TUB HOLDINGS LLC PP | — | — — | EC CORP | 2,100 NS | $745.0K EUR | 0.074% | DE |
| ZENAS BIOPHARMA INC ZENAS BIOPHARMA INC PIPE | — | — — | EC CORP | 38,208 NS | $747.0K | 0.074% | US |
| ELEMENT BIOSCIENCES INC ELEMENT BIOSCIENCES INC SER C PC PP | — | — — | EP CORP | 72,178 NS | $794.7K | 0.079% | US |
| JADE BIOSCIENCES INC | JBIO | 008064206 US0080642061 | EC CORP | 60,000 NS | $843.0K | 0.084% | US |
| ORUKA THERAPEUTICS INC ORUKA THERAPEUTICS INC PIPE | — | — — | EC CORP | 17,500 NS | $858.4K | 0.085% | US |
| PARABILIS MEDICINES INC PARABILIS MEDICINES INC SER F PC PP | — | — — | EP CORP | 149,200 NS | $1.00M | 0.100% | US |
| CONTINEUM THERAPEUTICS INC CONTINEUM THERAPEUTICS INC CL A | CTNM | 21217B100 US21217B1008 | EC CORP | 80,000 NS | $1.04M | 0.104% | US |
| SHOULDER INNOVATIONS INC SHOULDER INNOVATIONS INC 144A | — | — — | EC CORP | 73,451 NS | $1.07M | 0.106% | US |
| OUTSET MEDICAL INC | OM | 690145206 US6901452069 | EC CORP | 280,000 NS | $1.08M | 0.107% | US |
| ANNEXON INC | ANNX | 03589W102 US03589W1027 | EC CORP | 200,000 NS | $1.11M | 0.110% | US |
| RALLYBIO CORP CANDID THERAPEUTICS PIPE | — | — — | EC CORP | 819,208 NS | $1.15M | 0.114% | US |
| IQVIA HOLDINGS INC | IQV | 46266C105 US46266C1053 | EC CORP | 6,800 NS | $1.16M | 0.115% | US |
| INSIGHTEC LTD INSIGHTEC LTD SER G PC PP | — | — — | EP CORP | 1,824,838 NS | $1.26M | 0.125% | IL |
| UPSTREAM BIO INC | UPB | 91678A107 US91678A1079 | EC CORP | 145,000 NS | $1.30M | 0.130% | US |
| KARDIUM INC/US KARDIUM SRE D-7 PC PP (REDOMICILE CLOSING AUG… | — | — — | EP CORP | 2,440,148 NS | $1.32M | 0.131% | US |
| ENDEAVOR BIOMEDICINES INC ENDEAVOR BIOMEDICINES INC SERIES C PC PP | — | — — | EP CORP | 208,016 NS | $1.36M | 0.135% | US |
| MEDICAL MICROINSTRUMENTS INC MEDICAL MICROINSTRUMENTS INC SER C PC PP | — | — — | EP CORP | 47,257 NS | $1.45M | 0.144% | US |
| MBX BIOSCIENCES INC | MBX | 55287L101 US55287L1017 | EC CORP | 50,000 NS | $1.49M | 0.149% | US |
| APOGEE THERAPEUTICS INC | APGE | 03770N101 US03770N1019 | EC CORP | 19,277 NS | $1.62M | 0.162% | US |
| REVOLUTION MEDICINES INC | RVMD | 76155X100 US76155X1000 | EC CORP | 18,000 NS | $1.75M | 0.174% | US |
| BIOGEN INC | BIIB | 09062X103 US09062X1037 | EC CORP | 10,000 NS | $1.83M | 0.183% | US |
| TYRA BIOSCIENCES INC | TYRA | 90240B106 US90240B1061 | EC CORP | 50,000 NS | $1.92M | 0.191% | US |
| SCHOLAR ROCK HOLDING CORP | SRRK | 80706P103 US80706P1030 | EC CORP | 39,900 NS | $1.96M | 0.195% | US |
| TREVI THERAPEUTICS INC | TRVI | 89532M101 US89532M1018 | EC CORP | 180,000 NS | $2.15M | 0.214% | US |
| CLEERLY INC CLEERLY INC SER C PC PP | — | — — | EP CORP | 179,891 NS | $2.17M | 0.216% | US |